LI
RYTM icon

LRI Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History

LRI Investments’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$666 Hold
6
– – ﹤0.01% 1478
2026
Q1 		$522 Buy
+6
New +$583 ﹤0.01% 1371

Other funds holding RYTM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

LRI Investments's RYTM Position: Q2 2026 in Review

LRI Investments held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 6 shares worth $666. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

LRI Investments first reported a position in RYTM in Q1 2026 and has held it in 2 quarters since. 52 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • LRI Investments held 6 shares of Rhythm Pharmaceuticals worth $666 as of Q2 2026.
  • LRI Investments left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1478 holding.
  • LRI Investments first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 52 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.